House Oversight Committee Chairman Rep. Darrell Issa, California Republican, is concerned that a new Food and Drug Administration rule that would allow generic drug companies to change warning labels without approval has no health benefits, and was designed to placate special interest groups and could increase lawsuits. (Associated Press)
Featured Photo Galleries
Trump Transition: Here are the people Trump has picked for key positions so far
President-elect Donald Trump has announced a flurry of picks for his incoming administration. Get full coverage of the Trump transition from The Washingon Times.
